BioCentury
ARTICLE | Company News

Diaxonhit, Boehringer Ingelheim deal

September 9, 2013 7:00 AM UTC

Boehringer Ingelheim partnered with Diaxonhit to discover and characterize splice variants with Diaxonhit's SpliceArray discovery platform that have the potential to be therapeutic cancer targets. Boe...